A former manager at Genentech claims the company bypassed ethical and clinical guidelines in order to rush a promising drug through clinical trials.
The Scientist
Most Recent
Two medical professors contend that the pharmaceutical industry is really suffering from a drive to make only marginal improvements to existing drugs.
A researcher from the John Wayne Cancer Institute has settled his scientific misconduct case with the Office of Research Integrity.
Researchers track tumors as they develop, providing more support for the idea that cells with stem-cell-like properties underlie cancer growth and recurrence.
Lymphatic vessels grow towards two chemokines, revealing signals that could be important in cancer metastasis.
Japanese astronauts deliver an aquarium to the International Space Station to study the effects of microgravity on marine life.
Like commensal gut organisms, skin microbiota appear to help the mammalian immune system mature and stay regulated.
A US federal court rules that procedures in which a patient's own stem cells are extracted, manipulated, and reinjected should be regulated by the FDA.
The National Institutes of Health will fund 17 projects developing lab-on-a-chip applications to improve drug screening.
An approved cancer therapeutic makes hiding HIV susceptible to antiviral therapy.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
